Mirtazapin-Mepha 15 mg

Mirtazapin-Mepha 15 mg is a medicine authorised by Swissmedic under authorisation number 61342. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 April 2011 and the authorisation is valid without a time limit. ATC code N06AX11 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 61342
  • ATC N06AX11
  • Synthetic medicines
Authorisation data
Authorisation number61342
NameMirtazapin-Mepha 15 mg
Full nameMirtazapin-Mepha 15 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06AX11
First authorisation12 April 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Mirtazapin-Mepha 15 mg, FilmtablettenB12 April 2011
2Mirtazapin-Mepha 30 mg, FilmtablettenB12 April 2011
3Mirtazapin-Mepha 45 mg, FilmtablettenB12 April 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
610Tablette(n)N06AX1101.06.0.B
730Tablette(n)N06AX1101.06.0.B
8100Tablette(n)N06AX1101.06.0.B
110Tablette(n)N06AX1101.06.0.B
230Tablette(n)N06AX1101.06.0.B
3100Tablette(n)N06AX1101.06.0.B
430Tablette(n)N06AX1101.06.0.B
5100Tablette(n)N06AX1101.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Mirtazapin-Mepha 15 mg authorised in Switzerland?

Yes. Mirtazapin-Mepha 15 mg is authorised by Swissmedic under authorisation number 61342, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Mirtazapin-Mepha 15 mg have?

Mirtazapin-Mepha 15 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Mirtazapin-Mepha 15 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com